HONG KONG, Sept. 12, 2025 — Majestic Ideal Holdings Ltd (NASDAQ: MJID), hereinafter referred to as “the Company,” announced today that shareholders, during an Extraordinary General Meeting (referred to as “the Meeting”) held at 11:00 a.m. at the Company’s office located at 7/F, China United Plaza, 1002-1008, Tai Nan West Street, Cheung Sha Wan, Kowloon, Hong Kong, officially approved the proposal to alter the Company’s name. This approval is subject to and conditional upon the Registrar of Companies in the Cayman Islands granting its consent.
The Meeting was properly convened, with Ms. Ll, Yuk Yin Judy, serving as Chairperson in accordance with the Company’s Articles of Association. She declared the Meeting open and confirmed that the necessary quorum had been met.
Resolutions Approved
During the Meeting, the following special resolutions were thoroughly discussed and received unanimous approval:
Company Name Change
The Company’s English corporate name will transition from “Majestic Ideal Holdings Ltd” to “Ping An Biomedical Co., Ltd.”
Similarly, the Company’s Chinese corporate name will change from “威美控股有限公司” to “平安生物医药有限公司”.
This name alteration will become effective on the date the new English name and its corresponding dual foreign Chinese name are officially entered into the register maintained by the Registrar of Companies in the Cayman Islands, and on the date a certificate of incorporation reflecting this change is issued by the Registrar of Companies in the Cayman Islands.
Authority to Implement Name Change
The Meeting granted authority to any one director, the Company secretary, and/or its registered office provider to inform the Cayman Islands Registrar of Companies about these special resolutions, complete all requisite filings, and undertake any actions necessary for the name change to be put into effect.
Both special resolutions secured approval from a majority of at least two-thirds of the shareholders eligible to vote and either attending the Meeting in person or by proxy.
Corporate Statement
The Board of Directors holds the view that this approved name change will strengthen the Company’s corporate identity and align it more closely with its strategic emphasis on biomedical and healthcare technologies. The Company maintains its dedication to fostering innovation and solidifying its position as a sector leader.
About Majestic Ideal Holdings Ltd
Majestic Ideal Holdings Ltd operates as an integrated supply chain management provider for the apparel sector. It also serves as a progressive enterprise committed to delivering cutting-edge solutions within healthcare and biomedical technology. The proposed change in name signifies its dedication to advancing its core mission and establishing itself as an industry frontrunner.
CONTACT: For more information, please contact: Celestia Investor Relations Email: investors@celestiair.com
